[go: up one dir, main page]

MA26392A1 - Respirateur aerosol - Google Patents

Respirateur aerosol

Info

Publication number
MA26392A1
MA26392A1 MA26712A MA26712A MA26392A1 MA 26392 A1 MA26392 A1 MA 26392A1 MA 26712 A MA26712 A MA 26712A MA 26712 A MA26712 A MA 26712A MA 26392 A1 MA26392 A1 MA 26392A1
Authority
MA
Morocco
Prior art keywords
hfa
actuator
hydrofluoroalkane
heptafluoropropane
tetrafluoroethane
Prior art date
Application number
MA26712A
Other languages
English (en)
Inventor
Gaetano Brambilla
Isabella Penza
Alessandra Ferraris
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11443627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26392(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA26392A1 publication Critical patent/MA26392A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Nozzles (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MA26712A 2000-01-07 2002-06-25 Respirateur aerosol MA26392A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000010A IT1317720B1 (it) 2000-01-07 2000-01-07 Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.

Publications (1)

Publication Number Publication Date
MA26392A1 true MA26392A1 (fr) 2004-12-01

Family

ID=11443627

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26712A MA26392A1 (fr) 2000-01-07 2002-06-25 Respirateur aerosol

Country Status (23)

Country Link
US (1) US20050034720A1 (fr)
EP (1) EP1244487B1 (fr)
AT (1) ATE342081T1 (fr)
AU (1) AU2512801A (fr)
BR (1) BR0107730B1 (fr)
CA (1) CA2396273C (fr)
CZ (1) CZ303394B6 (fr)
DE (1) DE60123746T2 (fr)
DK (1) DK1244487T3 (fr)
DZ (1) DZ3243A1 (fr)
EG (1) EG22790A (fr)
ES (1) ES2273800T3 (fr)
HU (1) HU229516B1 (fr)
IT (1) IT1317720B1 (fr)
JO (1) JO2506B1 (fr)
MA (1) MA26392A1 (fr)
PL (1) PL198683B1 (fr)
PT (1) PT1244487E (fr)
SA (1) SA01210645B1 (fr)
SI (1) SI1244487T1 (fr)
SK (1) SK286139B6 (fr)
TN (1) TNSN01003A1 (fr)
WO (1) WO2001049350A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
WO2003026559A2 (fr) * 2001-09-28 2003-04-03 Kurve Technology, Inc Nebuliseur nasal
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
AU2003249623A1 (en) 2002-05-09 2003-12-12 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
US20070095342A1 (en) * 2005-10-18 2007-05-03 Bijan Olfati Accessorized inhaler
WO2008028092A2 (fr) 2006-08-30 2008-03-06 Kurve Technology, Inc. Dispositif de génération et de délivrance d'aérosol
BRPI0603695A (pt) * 2006-09-13 2008-04-29 Cesar Eduardo Marques Da Silva aerocámara para aplicação de medicamentos aerossol com válvula geométrica
EP2230934B8 (fr) 2007-12-14 2012-10-24 AeroDesigns, Inc Administration de produits alimentaires sous forme d'aérosols
EP2080507A1 (fr) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Formulations pharmaceutiques comprenant un médicament anticholinérgique
WO2011038872A1 (fr) 2009-10-02 2011-04-07 Chiesi Farmaceutici S.P.A. Formulations d'aérosol pharmaceutique de formotérol et de dipropionate de béclométasone
EP2512438B1 (fr) * 2009-12-16 2017-01-25 3M Innovative Properties Company Formulations et procédés pour le réglage de l'administration de particules d'une certaine taille dans un aérosol-doseur
WO2011076840A2 (fr) 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Préparation aérosol pour bronchopneumopathie chronique obstructive
EP2515854B1 (fr) 2009-12-23 2014-03-19 Chiesi Farmaceutici S.p.A. Formule d'aérosol pour COPD
PH12012501066A1 (en) 2009-12-23 2016-03-02 Chiesi Farm Spa Combination therapy for copd
KR101738712B1 (ko) 2009-12-23 2017-05-22 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 조합요법
US20150010527A1 (en) 2012-02-01 2015-01-08 Protalix Ltd. Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
US20150174158A1 (en) 2012-03-07 2015-06-25 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
JP6563950B2 (ja) 2013-12-30 2019-08-21 シエシー ファルマセウティチィ ソシエタ ペル アチオニ グリコピロニウム臭化物およびホルモテロールの組合せの安定な加圧エアゾール溶液組成物
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IT1244441B (it) * 1990-09-13 1994-07-15 Chiesi Farma Spa Dispositivo per l'inalazione boccale di farmaci aerosol
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
DK0585379T3 (da) * 1991-05-21 1999-06-21 Abbott Lab Aerosol-inhalationsindretning
HU216998B (hu) * 1991-08-29 1999-11-29 Broncho-Air Medizintechnik Ag. Orvosi készülék aeroszóladagok inhalálásához
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
ES2129117T3 (es) * 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
US5819730A (en) * 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
DK0735884T3 (da) * 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
EA000889B1 (ru) * 1995-04-14 2000-06-26 Глаксо Веллкам Инк. Дозирующий ингалятор дипропионата беклометазона
TR199701168T1 (xx) * 1995-04-14 1998-05-21 Glaxo Wellcome Inc. Flutikazon Propionat i�in �l��lm�� doz inhaleri.
BR9604977A (pt) * 1995-04-14 1998-06-09 Glaxo Wellcome Inc Inalador de dose medida sistema inalador de dose medida e uso do mesmo
EE03997B1 (et) * 1995-04-14 2003-04-15 Glaxo Wellcome Inc. Albuterooli doseeriv inhalaator
AU3811897A (en) 1996-07-24 1998-02-10 Oglios Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6461591B1 (en) * 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6193954B1 (en) * 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) * 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
JP2000112547A (ja) * 1998-10-05 2000-04-21 Mitsubishi Electric Corp 基板電圧発生回路および半導体集積回路装置
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
CA2347856C (fr) * 1998-11-13 2009-02-17 Jago Research Ag Poudre seche pour inhalation
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
WO2001019342A2 (fr) * 1999-09-11 2001-03-22 Glaxo Group Limited Preparation pharmaceutique renfermant du propionate de fluticasone
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
DZ3358A1 (fr) * 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
TR200401980T4 (tr) * 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
US6616193B2 (en) * 2001-10-03 2003-09-09 Kool, L.L.C. Ventilating system connector assembly and method of use
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
EP1415647A1 (fr) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. Beta-2-agonistes à activité de longue durée dans une formulation ultrafine
KR100947409B1 (ko) * 2002-03-01 2010-03-12 키에시 파르마슈티시 엣스. 피. 에이. 포모테롤 초미세 조성물

Also Published As

Publication number Publication date
HU229516B1 (en) 2014-01-28
CA2396273A1 (fr) 2001-07-12
HUP0300405A2 (hu) 2003-06-28
AU2512801A (en) 2001-07-16
DE60123746D1 (de) 2006-11-23
DE60123746T2 (de) 2007-10-11
SK9482002A3 (en) 2002-10-08
PL198683B1 (pl) 2008-07-31
ITMI20000010A0 (it) 2000-01-07
EP1244487B1 (fr) 2006-10-11
US20050034720A1 (en) 2005-02-17
SA01210645B1 (ar) 2007-07-31
CZ20022331A3 (cs) 2002-11-13
BR0107730B1 (pt) 2009-05-05
WO2001049350A1 (fr) 2001-07-12
IT1317720B1 (it) 2003-07-15
EP1244487A1 (fr) 2002-10-02
ES2273800T3 (es) 2007-05-16
EG22790A (en) 2003-08-31
ATE342081T1 (de) 2006-11-15
PL356849A1 (en) 2004-07-12
CA2396273C (fr) 2009-11-17
ITMI20000010A1 (it) 2001-07-07
SI1244487T1 (sl) 2007-04-30
HUP0300405A3 (en) 2003-07-28
CZ303394B6 (cs) 2012-08-29
SK286139B6 (sk) 2008-04-07
TNSN01003A1 (fr) 2003-04-03
BR0107730A (pt) 2003-02-25
DZ3243A1 (fr) 2001-07-12
DK1244487T3 (da) 2007-02-19
PT1244487E (pt) 2007-01-31
JO2506B1 (en) 2009-10-05

Similar Documents

Publication Publication Date Title
MA26392A1 (fr) Respirateur aerosol
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
ATE128350T1 (de) Pharmazeutische aerosolformulierung.
NO20010391L (no) Medisinske aerosolformuleringer
MY119074A (en) Pharmaceutical aerosol composition
CY1106904T1 (el) Φαρμακευτικη συνθεση αερολυματος περιεχουσα hfa 227 και hfa 134a
CA2445516A1 (fr) Distributeur-doseur destine a des agents liquides et en poudre
NO20030133D0 (no) Ny aerosolformulering inneholdende et polart fluorert molekyl
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
EP2612703A3 (fr) Matériau à particules
EP1110547A3 (fr) Hélium et néon comme moyen pour la délivrance d' un médicament par inhalateur
NO20034873L (no) Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering